ClassID:

20463

A61K31/5578 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Eicosanoids, e.g. leukotrienes or prostaglandins having a pentalene ring system, e.g. carbacyclin, iloprost

Recent Application in this class:
#1
20260069535
2026-03-12

NEBULIZER KITS AND USES THEREOF

#2
20260021109
2026-01-22

PROSTANOID RECEPTOR AGONISTS AS NON-TUBERCULOUS ANTI-MYCOBACTERIAL AGENTS

#3
20260007656
2026-01-08

METHODS AND COMPOSITIONS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, PNEUMONIA, BRONCHITIS, CYSTIC FIBROSIS, PULMONARY EDEMA, INTERSTITIAL LUNG DISEASE, SARCOIDOSIS, IDIOPATHIC PULMONARY FIBROSIS, ACUTE RESPIRATORY DISTRESS SYNDROME, PULMONARY ARTERIAL HYPERTENSION, ADN RESPIRATORY SYNCYTIAL VIRUS

#4
20260000680
2026-01-01

METHOD OF USING ILOPROST FOR TREATING FROSTBITE

#5
20250381199
2025-12-18

PHARMACEUTICAL PREPARATION FOR IMPROVING ABSORPTION AND POSTPRANDIAL HYPOGLYCEMIC ACTION OF INSULIN

#6
20250144117
2025-05-08

ILOPROST COMPOSITIONS AND FORMULATIONS THEREOF

#7
20250099484
2025-03-27

METHOD OF USING ILOPROST FOR TREATING FROSTBITE

#8
20250000873
2025-01-02

INHALED ILOPROST FOR RESCUE TREATMENT AND TREATMENT AS NEEDED IN PULMONARY HYPERTENSION

#9
20240366596
2024-11-07

TREATMENT OF HFPEF IN POST-MENOPAUSAL WOMEN WITH AN SGC STIMULATOR

#10
20240299414
2024-09-12

SUBCUTANEOUS OR INTRAMUSCULAR INJECTION FORMULATIONS OF ILOPROST

#11
20240299413
2024-09-12

METHOD OF TREATING SYSTEMIC SCLEROSIS WITH SYMPTOMATIC RAYNAUD'S PHENOMENON BY INTRAVENOUS OR SUBCUTANEOUS ILOPROST ADMINISTRATION

#12
20230263807
2023-08-24

TREPROSTINIL ILOPROST COMBINATION THERAPY

#13
20230158043
2023-05-25

PHARMACEUTICAL PREPARATION FOR IMPROVING ABSORPTION AND POSTPRANDIAL HYPOGLYCEMIC ACTION OF INSULIN

#14
20230088546
2023-03-23

COMPOSITIONS CONTAINING RAPID-ACTING INSULIN ANALOGUES

#15
20230069076
2023-03-02

COMPOSITIONS FOR THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION

#16
20220218874
2022-07-14

COMPOSITIONS AND METHODS OF MODULATING ENDOCHONDRAL OSSIFICATION AND BONE FORMATION

#17
20220168297
2022-06-02

METHODS AND COMPOSITIONS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, PNEUMONIA, BRONCHITIS, CYSTIC FIBROSIS, PULMONARY EDEMA, INTERSTITIAL LUNG DISEASE, SARCOIDOSIS, IDIOPATHIC PULMONARY FIBROSIS, ACUTE RESPIRATORY DISTRESS SYNDROME, AND PULMONARY ARTERIAL HYPERTENSION

#18
20210128680
2021-05-06

METHOD FOR TREATING CARDIOPULMONARY DISORDER

#19
20190358364
2019-11-28

Compositions and methods of modulating endochondral ossification and bone formation

#20
20190209585
2019-07-11

COMBINATION THERAPY COMPRISING A POLYUNSATURATED KETONE AND A SECOSTEROID

#21
20190175655
2019-06-13

DRY PLATELET COMPOSITION

#22
20190167696
2019-06-06

Method of treating hypertension

#23
20180221385
2018-08-09

A PHARMACEUTICAL PREPARATION FOR IMPROVING ABSORPTION AND POSTPRANDIAL HYPOGLYCEMIC ACTION OF INSULIN

#24
20180207175
2018-07-26

COMPOSITION FOR LOWERING INTRAOCULAR PRESSURE

#25
20180000958
2018-01-04

Compositions of jasmonate compounds and methods of use

#26
20170140533
2017-05-18

System and method for automated detection and monitoring of dysplasia and administration of immunotherapy and chemotherapy

#27
20170136064
2017-05-18

Dry platelet composition

#28
20170049822
2017-02-23

METHODS OF ENHANCING STEM CELL ENGRAFTMENT

#29
20170014424
2017-01-19

Administration of iloprost as aerosol bolus

#30
20160317552
2016-11-03

PHARMACEUTICAL FORMULATIONS FOR TREATING MALE SEXUAL DYSFUNCTIONS

#31
20160310505
2016-10-27

PROSTAMIDES FOR ENHANCEMENT OF LEPTIN PRODUCTION

#32
20160303040
2016-10-20

INJECTABLE PHARMACEUTICAL COMPOSITIONS COMPRISING PROSTACYCLIN

#33
20160175319
2016-06-23

Composition for the treatment of cystic fibrosis

#34
20160022678
2016-01-28

Therapeutic compositions containing macitentan

#35
20150328149
2015-11-19

Method for Administering an Antibiotic Dosage

#36
20150290153
2015-10-15

Administration of aerosolised iloprost

#37
20150140110
2015-05-21

Compositions of jasmonate compounds and methods of use

#38
20150104491
2015-04-16

SUSTAINED-RELEASE RESERVOIR IMPLANTS FOR INTRACAMERAL DRUG DELIVERY

#39
20150057325
2015-02-26

COMPOUNDS CAPABLE OF MODULATING/PRESERVING ENDOTHELIAL INTEGRITY FOR USE IN PREVENTION OR TREATMENT OF ACUTE TRAUMATIC COAGULOPATHY AND RESUSCITATED CARDIAC ARREST

#40
20150025255
2015-01-22

Process for preparing synthetic prostacyclins

#41
20140329824
2014-11-06

Therapeutic compositions containing macitentan

#42
20140194501
2014-07-10

Composition for eyelash growth

#43
20140044797
2014-02-13

PROSTACYCLIN AND ANALOGS THEREOF ADMINISTERED DURING SURGERY FOR PREVENTION AND TREATMENT OF CAPILLARY LEAKAGE

#44
20140018430
2014-01-16

Composition for the treatment of cystic fibrosis

#45
20130274261
2013-10-17

METHODS FOR TREATING PULMONARY HYPERTENSION

#46
20130089615
2013-04-11

Compositions of jasmonate compounds

#47
20130040898
2013-02-14

METHODS OF TREATMENT OF PATIENTS AT INCREASED RISK OF DEVELOPMENT OF ISCHEMIC EVENTS AND COMPOUNDS HEREOF

#48
20130017243
2013-01-17

SUSTAINED-RELEASE RESERVOIR IMPLANTS FOR INTRACAMERAL DRUG DELIVERY

#49
20130005711
2013-01-03

Fasudil in combination therapies for the treatment of pulmonary arterial hypertension

#50
20120190739
2012-07-26

EP2 and EP4 agonists as agents for the treatment of influenza a viral infection

#51
20120184622
2012-07-19

COMPOSITION FOR THE TREATMENT OF CYSTIC FIBROSIS

#52
20120004307
2012-01-05

ORAL TREATMENT OF DIGITAL ISCHEMIC LESIONS

#53
20110263498
2011-10-27

Method and composition for enhancement of male erectile function

#54
20110224236
2011-09-15

Treatment for pulmonary hypertension

#55
20110172308
2011-07-14

Antagonsim of PGF2a Receptor to Treat Hyertension Characterized by Activation of the Renin-Angiotensin-Aldosterone System

#56
20110171139
2011-07-14

FASUDIL IN COMBINATION THERAPIES FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

#57
20110136818
2011-06-09

Therapeutic compositions containing macitentan

#58
20110112094
2011-05-12

Methods of treating pulmonary hypertension

#59
20090170931
2009-07-02

EP2 and EP4 agonists as agents for the treatment of influenza a viral infection

#60
20090163450
2009-06-25

COMBINATIONS COMPRISING A PROSTAGLANDIN AND USES THEREOF

#61
20090143463
2009-06-04

Therapeutic agent and treatment method for ameliorating uremia

#62
20090054308
2009-02-26

Methods and compositions for treating pulmonary hypertension and related diseases and disorders

#63
20090035289
2009-02-05

DRY PLATELET COMPOSITION

#64
20070111983
2007-05-17

Fasudil in combination therapies for the treatment of pulmonary arterial hypertension

#65
20060147520
2006-07-06

Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation